[{"Assets_0_Q2_USD":1454459000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_2_Q2_shares":67233000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q2_shares":67487000.0,"StockholdersEquity_0_Q2_USD":984561000.0,"RevenuesConverted_2_Q2_USD":20267000.0,"RevenuesConverted_1_Q2_USD":7472000.0,"NetIncomeLossConverted_2_Q2_USD":-447510000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q2_shares":67487000.0,"NetIncomeLossConverted_1_Q2_USD":-241702000.0,"EarningsPerShareDiluted_2_Q2_USD":-6.66,"EarningsPerShareDiluted_1_Q2_USD":-3.58,"EarningsPerShareBasic_2_Q2_USD":-6.66,"EarningsPerShareBasic_1_Q2_USD":-3.58,"CommonStockSharesOutstanding_0_Q2_shares":67551000.0,"CommonStockSharesConverted_0_Q2_shares":67551000.0,"NetCashProvidedByUsedInOperatingActivitiesConverted_2_Q2_USD":-348975000.0,"WeightedAverageNumberOfSharesOutstandingBasic_2_Q2_shares":67233000.0,"Ticker":"BLUE","CIK":"1293971","name":"BLUEBIRD BIO, INC.","OfficialName":"bluebird bio Inc. Common Stock","form":"10-Q","period":"20210630","fy":"2021.0","fp":"Q2","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"301448421.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Biological Products (No Diagnostic Substances)","Market":"NASDAQ","SP500":"nan","filed":"20210809"}]